The NMDA receptor, second edition. Edited by G. L. Collinridge, and J. C. Watkins. Oxford University Press, Oxford, 1994. pp. 503. £30. ISBN 019262502 0 (Pbk)
✍ Scribed by M. Maginn
- Book ID
- 102261953
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 96 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
and neuroprotection. The use of doparnine agonists in the treatment of Parkinson's disease is briefly reviewed. The final section deals with dementia and the related hypothalamic hyperactivity including Alzheimer's disease (AD), senile dementia Alzheimer's type (SDAT) and vascular dementia (VD). The role of cholinesterase inhibitors in Alzheimer's disease and their effects on the amyloid protein precursor (APP) processing is discussed along with the potential role of phenyl carbamates and derivatives as cholinesterase inhibitors. The role of nitric oxide is only briefly discussed in relation to excitatory neurotoxicity, more emphasis being placed on the
📜 SIMILAR VOLUMES